OBJECTIVE: To determine differences in quality of life (QOL) between patients with head and neck cancer who receive chemoradiation versus chemoradiation and neck dissection. METHODS: A prospective cohort study was conducted at two tertiary otolaryngology clinics and a Veterans Administration hospital. SAMPLE: 103 oropharyngeal patients with Stage IV squamous cell carcinoma treated via chemoradiation +/- neck dissection. INTERVENTION: self-administered health survey to collect health, demographic, and QOL information pretreatment and 1 year later. MAIN OUTCOME MEASURES: QOL via SF-36 and HNQoL. Descriptive statistics were calculated for health/clinical characteristics, demographics, and QOL scores. t tests evaluated changes in QOL over time. RESULTS: Sixty-five patients underwent chemoradiation and 38 patients underwent chemoradiation and neck dissection. Only the pain index of the SF-36 showed a significant difference between groups (P < 0.05) with the neck dissection group reporting greater pain. CONCLUSIONS: After post-treatment neck dissection, patients experience statistically significant decrement in bodily pain domain scores, but other QOL scores are similar to those of patients who underwent chemoradiation alone.
OBJECTIVE: To determine differences in quality of life (QOL) between patients with head and neck cancer who receive chemoradiation versus chemoradiation and neck dissection. METHODS: A prospective cohort study was conducted at two tertiary otolaryngology clinics and a Veterans Administration hospital. SAMPLE: 103 oropharyngeal patients with Stage IV squamous cell carcinoma treated via chemoradiation +/- neck dissection. INTERVENTION: self-administered health survey to collect health, demographic, and QOL information pretreatment and 1 year later. MAIN OUTCOME MEASURES: QOL via SF-36 and HNQoL. Descriptive statistics were calculated for health/clinical characteristics, demographics, and QOL scores. t tests evaluated changes in QOL over time. RESULTS: Sixty-five patients underwent chemoradiation and 38 patients underwent chemoradiation and neck dissection. Only the pain index of the SF-36 showed a significant difference between groups (P < 0.05) with the neck dissection group reporting greater pain. CONCLUSIONS: After post-treatment neck dissection, patients experience statistically significant decrement in bodily pain domain scores, but other QOL scores are similar to those of patients who underwent chemoradiation alone.
Authors: Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson Journal: N Engl J Med Date: 1991-06-13 Impact factor: 91.245
Authors: K Albuquerque; J Cirrone; H Aziz; G Har-El; K Sundaram; F Dipillo; L Fulton; I Aral; A Schulsinger; M Rotman Journal: Am J Clin Oncol Date: 2001-12 Impact factor: 2.339
Authors: Douglas B Chepeha; Rodney J Taylor; Judith C Chepeha; Theodoros N Teknos; Carol R Bradford; Pramod K Sharma; Jeffrey E Terrell; Gregory T Wolf Journal: Head Neck Date: 2002-05 Impact factor: 3.147
Authors: Jeffrey E Terrell; David L Ronis; Karen E Fowler; Carol R Bradford; Douglas B Chepeha; Mark E Prince; Theodoros N Teknos; Gregory T Wolf; Sonia A Duffy Journal: Arch Otolaryngol Head Neck Surg Date: 2004-04
Authors: Ian Ganly; Jennifer Bocker; Diane L Carlson; Salvatore D'Arpa; Maria Coleman; Nancy Lee; David G Pfister; Jatin P Shah; Snehal G Patel Journal: Head Neck Date: 2010-11-04 Impact factor: 3.147
Authors: Brittany Barber; Margaret McNeely; K Ming Chan; Rhys Beaudry; Jaret Olson; Jeffrey Harris; Hadi Seikaly; Daniel O'Connell Journal: Trials Date: 2015-05-30 Impact factor: 2.279